All Updates

All Updates

icon
Filter
Partnerships
Cybin partners with Fluence to expand EMBARK training program for CYB003 trial
Psychedelic Medicine
Sep 26, 2023
This week:
Listing
Pony.ai files for US IPO
Auto Tech
Yesterday
Product updates
MineOS launches DSR management 2.0
Digital Privacy Tools
Yesterday
Product updates
LatticeFlow launches the first evaluation framework for EU AI Act compliance
Generative AI Infrastructure
Yesterday
Partnerships
Zscaler and Okta partner to enhance zero trust security initiatives
Identity & Access Management
Oct 16, 2024
Partnerships
Zscaler and Okta partner to enhance zero trust security initiatives
Next-gen Cybersecurity
Oct 16, 2024
Funding
Herald raises USD 12 million in Series A funding to enhance AI capabilities
InsurTech: Infrastructure
Oct 16, 2024
Partnerships
ActiveViam partners with MongoDB to enhance real-time data analytics for financial industry
Data Infrastructure & Analytics
Oct 16, 2024
Management news
CapWay shuts down operations
Neobanks
Oct 16, 2024
Funding
LanzaTech secures USD 3 million from US DOE to advance CO2 conversion
Carbon Capture, Utilization & Storage (CCUS)
Oct 16, 2024
Industry news
Denmark to invest USD 2.1 billion in climate transition research
Livestock Biotech
Oct 16, 2024
Psychedelic Medicine

Psychedelic Medicine

Sep 26, 2023

Cybin partners with Fluence to expand EMBARK training program for CYB003 trial

Partnerships

  • Canadian psychedelic biotech company Cybin has partnered with Fluence, a psychedelic therapy training company, to support Cybin's EMBARK facilitator training program. The program is related to operating and expanding a multi-site Phase III clinical trial of CYB003, a psilocybin analog for major depressive disorder.

  • Under the terms of the agreement, Fluence will assist in selecting and training facilitators for the trial and provide additional video content and training to enhance facilitator competencies. The collaboration aims to create a scalable program that supports the Phase III trial. 

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.